Intracellular signalling pathways have provided excellent resource for drug development
particularly in the development of cancer therapeutics. A wide variety of malignancies …

Radiation therapy is one of the most important treatment modalities for thoracic tumors.
Despite significant advances in radiation techniques, radiation-induced lung injury (RILI) still …

Background Radiation-induced lung fibrosis (RILF) is a severe and life-threatening
complication of thoracic radiotherapy. Cell death is the key issue in RILF. Ferroptosis is a …

Radiation-induced lung injury (RILI) is one of the most common and fatal complications of
thoracic radiotherapy. Cell death is the critical point in RILI. Ferroptosis is discovered …

Radiation‐induced lung injury (RILI) mainly contributes to the complications of thoracic
radiotherapy. RILI can be divided into radiation pneumonia (RP) and radiation‐induced lung …

Radiation-induced lung injury (RILI) is a common complication in radiotherapy of thoracic
tumors and limits the therapeutic dose of radiation that can be given to effectively control …

Radiation therapy is an important modality in the treatment of lung cancer, but it can lead to
radiation pneumonitis, and eventually radiation fibrosis. To date, only few available drugs …

Radiation‐induced lung injury (RILI) is the major complication of thoracic radiation therapy,
and no effective treatment is available. This study explored the role of high‐mobility group …

Radiotherapy (RT) is an effective treatment option for multiple thoracic malignant tumors,
including lung cancers, thymic cancers, and tracheal cancers. Radiation-induced lung injury …

Radiation treatments often unfavorably damage neighboring healthy organs and cause a
series of radiation sequelae, such as radiation‐induced hematopoietic system diseases …